ARTICLE | Company News
Sirion, Laboratorios Sophia deal
July 31, 2006 7:00 AM UTC
Laboratorios Sophia granted Sirion exclusive U.S. rights to develop and commercialize ST-603, a topical cyclosporine A, for ophthalmic use. Sirion plans to start Phase III testing of ST-603 in the fi...